size is expected to reach USD 1,154.2 million by 2027 and is registering a commendable CAGR of 9.2% From 2020-2027 The rise in the cases of chronic diseases such as diabetes and cancer is a key factor fueling market growth. Unhealthy lifestyle habits of smoking and alcohol consumption have resulted in the increased prevalence of non-communicable diseases which in turn drives the global market. In addition to this, physicians higher recommendation for anti-biofilm wound dressing products to treat chronic diseases further drives the market growth. A rise in the incidence of injuries during participation in sports and recreational activities propels the growth of the market. Apart from that, huge investment in healthcare infrastructure, technological advancements, and favorable government policies are also augmenting the growth of the global market for anti-biofilm wound dressing.